DIFFERENTIAL SUSCEPTIBILITY TO ACTIVATION-INDUCED APOPTOSIS AMONG PERIPHERAL TH1 SUBSETS - CORRELATION WITH BCL-2 EXPRESSION AND CONSEQUENCES FOR AIDS PATHOGENESIS
E. Ledru et al., DIFFERENTIAL SUSCEPTIBILITY TO ACTIVATION-INDUCED APOPTOSIS AMONG PERIPHERAL TH1 SUBSETS - CORRELATION WITH BCL-2 EXPRESSION AND CONSEQUENCES FOR AIDS PATHOGENESIS, The Journal of immunology, 160(7), 1998, pp. 3194-3206
It has been proposed that HIV infection is associated with an imbalanc
e in Th1 and Th2 subsets. Recent reports indicate that Th1 and Th2 eff
ecters differ in their susceptibility to activation-induced apoptosis.
To determine whether increased T cell apoptosis in HIV-infected patie
nts contributes to alterations in cytokine synthesis, we performed sin
gle-cell analysis of type 1 and type 2 cytokine production by CD4 and
CD8 T cells, simultaneously with detection of apoptosis. We demonstrat
e that a differential alteration in representation of Th1 subsets, rat
her than commitment of T cells to secrete Th2 cytokines, occurs throug
hout HIV infection. A significant decrease in the number of IL-2- or T
NF-alpha-producing T cells was observed, whereas those producing IFN-g
amma remained preserved. Furthermore, there is a gradient of susceptib
ility to activation-induced apoptosis (IL-2 < IFN-gamma < TNF-alpha) a
mong the different Th1 subsets. This gradient was detected in both CD4
and CD8 subsets, as well as in control donors and HIV-infected patien
ts, in whom the susceptibility to apoptosis of IL-2 and IFN-gamma prod
ucers was increased compared with controls. This differential intrinsi
c apoptosis susceptibility of Th1 effectors was found to be tightly re
gulated by Bcl-2 expression. In HIV-infected persons, disappearance of
IL-2-producing T cells was a good indicator of disease progression an
d was correlated with the progressive shrinkage of the CD4(+)CD45RA(+)
T cell compartment and a gradual increased susceptibility to activati
on-induced apoptosis of the IL-2-producing subset. This close relation
ship between the CD45RA/CD35R0 ratio, the level of type 1 cytokine pro
duction, and susceptibility to apoptosis should be considered in HIV-i
nfected patients under antiviral or immune-based therapies.